9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2023

RALEIGH, NC / ACCESSWIRE / May 15, 2023 / 9 Meters Biopharma, Inc. (Nasdaq:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today provided

Related Keywords

Chicago ,Illinois ,United States ,Nevada ,Las Vegas ,John Temperato ,Al Medwar ,Clinical Development ,Meters Biopharma Inc View ,Facebook ,Meters Biopharma Inc ,Investor Relations Corporate Communications ,Linkedin ,Nasdaq ,Chief Executive Officer ,Short Bowel Syndrome ,Practice Conference ,Investigational New Drug ,Digestive Disease Week ,Annual Report ,Quarterly Reports ,Investor Relations ,Inc View ,Gefallene Big Techs ,Meters ,Iopharma ,Rovides ,Business ,Update ,Reports ,Financial ,Results ,First ,Quarter ,023 ,